Showing results (381-390 of 657) with videos related to
Sort By:
Pageof 66
The Lancet. Microbe|July 30, 2022
Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trialDaniel Jenkin, Adam J Ritchie, Jeremy Aboagye, et al.The Lancet. Microbe|July 19, 2022
Investigating drug resistance of Mycobacterium leprae in the Comoros: an observational deep-sequencing studySofie Marijke Braet, Agathe Jouet, Alexandra Aubry, et al.The Lancet. Microbe|March 25, 2023
Wastewater concentrations of human influenza, metapneumovirus, parainfluenza, respiratory syncytial virus, rhinovirus, and seasonal coronavirus nucleic-acids during the COVID-19 pandemic: a surveillance studyAlexandria B Boehm, Bridgette Hughes, Dorothea Duong, et al.The Lancet. Microbe|March 3, 2023
Efficacy of SARS-CoV-2 vaccines and the dose-response relationship with three major antibodies: a systematic review and meta-analysis of randomised controlled trialsZhi-Rong Yang, Yi-Wen Jiang, Fu-Xiao Li, et al.The Lancet. Microbe|March 12, 2023
Predicting Vibrio cholerae infection and symptomatic disease: a systems serology studyKirsten E Wiens, Anita S Iyer, Taufiqur R Bhuiyan, et al.The Lancet. Microbe|February 21, 2023
Evidence of widespread endemic populations of highly multidrug resistant Klebsiella pneumoniae in hospital settings in Hanoi, Vietnam: a prospective cohort studyMy H Pham, Le Thi Hoi, Mathew A Beale, et al.The Lancet. Microbe|February 12, 2023
Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort studyJinnethe Reyes, Lauren Komarow, Liang Chen, et al.The Lancet. Microbe|February 3, 2023
Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysisBradley J Langford, Miranda So, Marina Simeonova, et al.The Lancet. Microbe|February 16, 2026
The effect of pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine on nasopharyngeal colonisation following human infection challenge with serotype 3 and serotype 6B (PREVENTING PNEUMO 2): a double-masked, randomised, controlled, phase 4 trialKonstantinos Liatsikos, Angela Hyder-Wright, Kelly Davies, et al.Pageof 66